← Eichor
Study identifier: NCT05965518 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Adults With HIV

Condition: HIV · Arterial Stiffness · Cognitive Dysfunction  ·  Sponsor: University of Alabama at Birmingham

PhaseNA
Planned participants60
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersNo

About this study

This is a single site, randomized exercise trial with individuals at least 50 years of age living with HIV who experience suboptimal cognition. The overall goals of this proposal are to determine whether 16 weeks of structured high-intensity interval training (HIIT) can overcome vascular and cognitive impairments (Aim 1) to a greater extent than continuous moderate exercise. Additionally, investigator will seek to identify barriers to engagement in exercise and the participants' perceptions of the study and exercise interventions (Aim 2). This study will enroll 60 participants in Birmingham, Alabama. Data collection will occur at each visit, with baseline data collected at the initial visit with a 3-month follow-up occurring following completion of the intervention.

This description comes directly from the study's public registry record.

Talk to the study team

Raymond Jones, Ph.D.  ·  205-996-3569  ·  raymondjones@uabmc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Alabama at BirminghamBirmingham, Alabama, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05965518